Independent medication information Not a pharmacy · Not a substitute for medical advice
Psilocybin mushrooms / Mushroom variety

Penis Envy mushrooms

Identity, uses and research, side effects, dosage context, pricing and online access.

Mushroom varietyPsilocybin mushrooms
Reference namePenis Envy mushrooms
Entry typeMushroom variety
CategoryPsilocybin mushrooms
SpeciesPsilocybe cubensis
Cultivated namePenis Envy
Name abbreviationPE

DrugRX editorial reference · Sources consulted · Not independently medically reviewed

Psilocybe cubensis mushrooms photographed by Mädi

Psilocybe cubensis species illustration: Golden Teacher pictured. This photograph does not identify the variety discussed on this page.

Mädi / Wikimedia Commons · CC BY-SA 3.0

About Penis Envy mushrooms

Penis Envy is a cultivated Psilocybe cubensis variety name. It does not identify a separate psychoactive chemical or a standardized medical preparation.

Also searched as: Penis Envy · PE mushrooms

PRICE, COST & AVAILABILITY

Buy Penis Envy mushrooms: pricing & legal access

Penis Envy mushrooms online: availability & product information

Psilocybin and psilocin are federally controlled. A marketplace variety name does not establish lawful delivery or product contents. DrugRX does not provide a seller directory, street-price benchmark or consumption recommendation.

Pricing status: No live price feed or verified quote. DrugRX does not sell or dispense products.

Sources: DEA — Controlled substances alphabetical list (October 2026)

DETAILED REFERENCE

Penis Envy mushrooms information

Identity and related names

Penis Envy and Albino Penis Envy are distinct cultivated labels within the P. cubensis reference. Neither name establishes identity, purity or consistency for a sample.

Sources: Controlled study of 14 P. cubensis strains (2026)

What potency studies show

A 2026 controlled study measured different tryptamine profiles across P. cubensis strains, including Penis Envy and Albino Penis Envy. It found a higher psilocin content in the tested Penis Envy material than in several other tested strains. This is not a guarantee for every sample or a clinical equivalence chart.

Sources: Controlled study of 14 P. cubensis strains (2026)

Side effects and dosage context

Variety-specific rates of adverse effects and a validated clinical dose are not established here. General psilocybin risks still apply, and a descriptive label cannot substitute for measured composition.

Sources: DEA — Psilocybin

Species and cultivated identity

Penis Envy is used as a cultivated name within P. cubensis. It is not a species-level scientific name, and a label does not independently confirm a specimen’s lineage.

Sources: P. cubensis genetics and research gaps (2025)

Psilocybin, psilocin and measured potency

A controlled study included Penis Envy among named P. cubensis samples. Measurements characterized those tested materials. An observed chemical difference should not be converted into a guaranteed potency multiplier for every specimen using the same name.

Sources: Controlled study of 14 P. cubensis strains (2026)

Appearance is not chemical verification

Physical features or photographs cannot establish a specimen’s active-compound content. The naming of a cultivated lineage, taxonomic identification and laboratory measurement are different forms of information.

Sources: P. cubensis genetics and research gaps (2025) · Controlled study of 14 P. cubensis strains (2026)

Penis Envy versus Albino Penis Envy

The two names should not be merged as aliases of a single product. Keep sample measurements attached to the actual tested material rather than extrapolating a fixed multiplier between names.

Sources: Controlled study of 14 P. cubensis strains (2026)

Sources and editorial notes

Prepared by DrugRX using the references linked below. Sources were consulted on 2026-10-31. This page has not been independently reviewed by a clinician. Research findings, medication approval and legal permission are separate questions.

  1. Controlled study of 14 P. cubensis strains (2026)
  2. DEA — Psilocybin
  3. P. cubensis genetics and research gaps (2025)
  4. DEA — Controlled substances alphabetical list (October 2026)

Legal information is a dated U.S. reference. Product rules and local laws may change. Where the evidence does not establish a dose, interaction profile or price, the page states that limitation.